Community Research and Development Information Service - CORDIS

Reg-X310: new disruptive medicine for faster exit from aplasia afetr agressive chemotherapy of hematologic malignancies

From 2018-11-01 to 2019-04-30, ongoing project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

France

Call for proposal:

H2020-SMEInst-2018-2020-1See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

REGSTEM
France

EU contribution: EUR 50 000


24 RUE DU FAUBOURG SAINT-JACQUES
75014 PARIS
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top